Placental transfer of tyrosine kinase inhibitors used for chronic myeloid leukemia treatment.

about

Breastfeeding in Patients with Chronic Myeloid Leukaemia: Case Series with Measurements of Drug Concentrations in Maternal Milk and Literature Review.

P2860

Q54110129-8EB3098D-0131-4E56-B9ED-71DACDC9CB96

P2860

Placental transfer of tyrosine kinase inhibitors used for chronic myeloid leukemia treatment.

Item

http://www.wikidata.org/entity/Q38681424

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Placental transfer of tyrosine ...... ic myeloid leukemia treatment.

@en

type

Item

label

Placental transfer of tyrosine ...... ic myeloid leukemia treatment.

@en

prefLabel

Placental transfer of tyrosine ...... ic myeloid leukemia treatment.

@en

P1476

Placental transfer of tyrosine ...... ic myeloid leukemia treatment.

@en

P2093

Alexey Zeifman

http://www.w3.org/2001/XMLSchema#string

Anna Turkina

http://www.w3.org/2001/XMLSchema#string

Dorel Guranda

http://www.w3.org/2001/XMLSchema#string

Ekaterina Chelysheva

http://www.w3.org/2001/XMLSchema#string

Evgenia Polushkina

http://www.w3.org/2001/XMLSchema#string

Ghermes Chilov

http://www.w3.org/2001/XMLSchema#string

Igor Shokhin

http://www.w3.org/2001/XMLSchema#string

Khamida Kazakbaeva

http://www.w3.org/2001/XMLSchema#string

Roman Shmakov

http://www.w3.org/2001/XMLSchema#string

Sergey Aleshin

http://www.w3.org/2001/XMLSchema#string

P2860

The concept of treatment-free remission in chronic myeloid leukemia

Philadelphia chromosome-positive leukemias: from basic mechanisms to molecular therapeutics

Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells

Safety and efficacy of imatinib in CML over a period of 10 years: data from the randomized CML-study IV.

A dramatic fetal outcome following transplacental transfer of dasatinib.

Application of quantitative structure-activity relationships for modeling drug and chemical transport across the human placenta barrier: a multivariate data analysis approach.

Tyrosine kinase inhibitors and pregnancy.

Physiologic changes in pregnancy and their effect on drug disposition.

Drug transfer and metabolism by the human placenta.

The development of imatinib as a therapeutic agent for chronic myeloid leukemia.

P304

733-738

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/10428194.2017.1347929

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Oksana Oksenjuk

P577

2017-07-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28703026

http://www.w3.org/2001/XMLSchema#string

P921

chronic myeloid leukemia

Placental transfer of tyrosine kinase inhibitors used for chronic myeloid leukemia treatment.

about

P2860

P2860

Placental transfer of tyrosine kinase inhibitors used for chronic myeloid leukemia treatment.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921